Eficacia de los agentes anti-TNFα en una cohorte de pacientes con artritis reumatoide en Costa Rica

The use of anti-TNF in patients that disease previously resistant to conventional DMAR achieved a 45% EULAR remission. The age in which the therapy starts; long-standing disease and the higher DAS 28, are negative predictors of treatment response to anti-TNF therapy.